Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar I disorder
- PMID: 26773991
- PMCID: PMC4715863
- DOI: 10.1016/j.comppsych.2015.10.003
Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar I disorder
Abstract
Background: Published data suggest that cannabis use is associated with several negative consequences for individuals with bipolar disorder (BD), including new manic episode onset, psychosis, and functional disability. Yet much less is known about cannabis use disorders (CUDs) in this population, especially in more acutely symptomatic groups.
Methods: To evaluate correlates of CUD comorbidity in BD, a retrospective chart review was conducted for 230 adult patients with bipolar I disorder (BDI) who were admitted to a university-affiliated private psychiatric hospital. Using a computer algorithm, a hospital administrator extracted relevant demographic and clinical data from the electronic medical record for analysis.
Results: Thirty-six (16%) had a comorbid CUD. CUD comorbidity was significantly associated with younger age, manic/mixed episode polarity, presence of psychotic features, and comorbid nicotine dependence, alcohol use disorder (AUD), and other substance use disorders, but was associated with decreased likelihood of anxiety disorder comorbidity. With the exception of manic/mixed polarity and AUD comorbidity, results from multivariate analyses controlling for the presence of other SUDs were consistent with univariate findings.
Conclusion: Patients with BD and comorbid CUDs appear to be a complex population with need for enhanced clinical monitoring. Given increasing public acceptance of cannabis use, and the limited availability of evidenced-based interventions targeted toward CUDs in BD, psychoeducation and other treatment development efforts appear to be warranted.
Copyright © 2015 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors have no conflicts to declare.
Similar articles
-
Alcohol use disorders are associated with increased affective lability in bipolar disorder.J Affect Disord. 2017 Jan 15;208:316-324. doi: 10.1016/j.jad.2016.09.062. Epub 2016 Oct 14. J Affect Disord. 2017. PMID: 27810713
-
Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.Isr J Psychiatry Relat Sci. 2016;53(3):10-15. Isr J Psychiatry Relat Sci. 2016. PMID: 28492376
-
Seasonal pattern of manic episode admissions among bipolar I disorder patients is associated with male gender and presence of psychotic features.J Affect Disord. 2016 Jan 15;190:123-127. doi: 10.1016/j.jad.2015.10.002. Epub 2015 Oct 23. J Affect Disord. 2016. PMID: 26497765
-
The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: A systematic review with meta-analysis and meta-regression.Neurosci Biobehav Rev. 2019 Jun;101:78-84. doi: 10.1016/j.neubiorev.2019.04.004. Epub 2019 Apr 8. Neurosci Biobehav Rev. 2019. PMID: 30974123
-
Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review.Psychol Med. 2021 Feb;51(3):353-364. doi: 10.1017/S0033291720005449. Epub 2021 Feb 4. Psychol Med. 2021. PMID: 33536109 Review.
Cited by
-
A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness.Am J Drug Alcohol Abuse. 2021 Sep 3;47(5):535-547. doi: 10.1080/00952990.2021.1946071. Epub 2021 Jul 19. Am J Drug Alcohol Abuse. 2021. PMID: 34280058 Free PMC article.
-
Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2-Metabolome, immunome, synaptome.Front Psychiatry. 2023 Oct 3;14:1182536. doi: 10.3389/fpsyt.2023.1182536. eCollection 2023. Front Psychiatry. 2023. PMID: 37854446 Free PMC article. Review.
-
Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence.Psychopharmacology (Berl). 2022 May;239(5):1231-1249. doi: 10.1007/s00213-021-06001-8. Epub 2021 Nov 6. Psychopharmacology (Berl). 2022. PMID: 34741634 Free PMC article. Review.
-
A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset.Brain Sci. 2023 Jul 27;13(8):1130. doi: 10.3390/brainsci13081130. Brain Sci. 2023. PMID: 37626487 Free PMC article.
-
Cannabis use and mood disorders: a systematic review.Front Public Health. 2024 Apr 9;12:1346207. doi: 10.3389/fpubh.2024.1346207. eCollection 2024. Front Public Health. 2024. PMID: 38655516 Free PMC article.
References
-
- Levin FR, Hennessy G. Bipolar disorder and substance abuse. Biol Psychiatry. 2004;56:738–48. - PubMed
-
- Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61:807–16. - PubMed
-
- Grant BF, Stinson FS, Hasin DS, Dawson DA, Chou SP, Ruan WJ, et al. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66:1205–15. - PubMed
-
- Garcia-Portilla MP, Saiz PA, Benabarre A, Florez G, Bascaran MT, Díaz EM, et al. Impact of substance use on the physical health of patients with bipolar disorder. Acta Psychiatr Scand. 2010;121:437–45. - PubMed
-
- Sherwood Brown E, Suppes T, Adinoff B, Rajan Thomas N. Drug abuse and bipolar disorder: comorbidity or misdiagnosis? J Affect Disord. 2001;65:105–15. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical